Numeric Investors’s Amicus Therapeutics FOLD Stock Holding History

Numeric Investors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.77M	Buy	192,431 +169,000	+721%	+$2.32M	0.02%	551
2017 Q3	$353K	Buy	+23,431	New	+$310K	﹤0.01%	953
2016 Q3	–	Sell	-75,900	Closed	-$414K	–	1102
2016 Q2	$414K	Buy	+75,900	New	+$531K	﹤0.01%	792
2015 Q3	–	Sell	-57,900	Closed	-$819K	–	1037
2015 Q2	$819K	Sell	57,900 -377,000	-87%	-$4.53M	0.01%	537
2015 Q1	$4.73M	Buy	434,900 +405,700	+1,389%	+$3.58M	0.06%	258
2014 Q4	$243K	Sell	29,200 -495,342	-94%	-$3.4M	﹤0.01%	750
2014 Q3	$3.12M	Buy	+524,542	New	+$2.75M	0.05%	283

Other funds holding FOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Numeric Investors's FOLD Position: Q4 2017 in Review

Numeric Investors increased its Amicus Therapeutics (FOLD) stake by 721% in Q4 2017, buying an estimated $2.32M and bringing the position to 192,431 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #551.

Numeric Investors first reported a position in FOLD in Q3 2014 and has held it in 7 quarters since. The position peaked at $4.73M in Q1 2015. 185 funds tracked by Wall St. Rank hold FOLD as of Q4 2017.

Numeric Investors held 192,431 shares of Amicus Therapeutics worth $2.77M as of Q4 2017.
Numeric Investors bought 169,000 Amicus Therapeutics shares in Q4 2017, an estimated $2.32M.
Amicus Therapeutics made up 0.02% of Numeric Investors's portfolio in Q4 2017, its #551 holding.
Numeric Investors first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 7 quarters since.
Numeric Investors's Amicus Therapeutics position peaked at $4.73M in Q1 2015.
185 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.